Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid

British Journal of Cancer

Volumn 86, Issue 6, 2002, Pages 912-916

  Ito, Y ^a   Yoshida, H ^a   Nakano, K ^a   Kobayashi, K ^a   Yokozawa, T ^a   Hirai, K ^a   Matsuzuka, F ^a   Matsuura, N ^a   Kakudo, K ^a   Kuma, K ^a   Miyauchi, A ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Caveolin 1; Immunohistochemistry; Thyroid carcinoma

Indexed keywords

CAVEOLIN 1; POLYCLONAL ANTIBODY;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOMA; CARCINOMA, PAPILLARY; CAVEOLIN 1; CAVEOLINS; HUMANS; IMMUNOHISTOCHEMISTRY; THYROID NEOPLASMS;

EID: 18344365571     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600172     Document Type: Article

References (30)

1. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenecity
2. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities
3. Hypermethylation of the cavolin-1 gene promoter in prostate cancer
4. Caveolin-1 expression in advanced-stage ovarian carcinoma - A clinicopathological study
5. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain
6. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers
7. Reciprocal regulation of neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Implications for human breast cancer
8. Elevated expression of caveolin-1 in adenocarcinoma of the colon
9. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo
10. Caveolae, DIGs, and dynamics of sphingolipid-cholesterol microdomains
11. Invasion activating caveolin-1 mutation in human scirrhous breast cancers
12. Vascular endothelial growth factor gene and protein: Strong expression in thyroiditis and thyroid carcinoma
13. Constitutive and growth factor-regulated phosphoryhtion of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src/Cav-1/Grb7 signaling cassette
14. Tumor cell growth inhibition by caveolin reexpression in human breast cancer cells
15. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin
16. The demise of follicular carcinoma of the thyroid gland
17. Angiogenesis activator and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1
18. Regulated migration of epidermal growth factor receptor from caveolae
19. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane
20. Reduction of caveolin 1 gene expression in lung carcinoma cell lines
21. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation
22. Poorly differentiated carcinoma of the thyroid. A clinicopathologica entity for a high-risk group of papillary and follicular carcinomas
23. Mutational analysis of the properties of caveolin-1: A novel role for the C-terminal domain in mediating homotypic caveolin-caveolin interactions
24. Targeting of a G alpha subunit (Gil alpha) and c-Src tyrosin kinase to caveolae membranes: Clarifying the role of N-myristoylation
25. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer
26. Expression of c-erbB-2 oncoprotein in human thyroid tumours
27. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues
28. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas
29. Elevated expression of caveolin is associated with prostate and breast cancer
30. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker